Hikal informs about transcript of the earnings call

16 Nov 2022 Evaluate

In continuation of its letters dated November 08, 2022 and November 09, 2022 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hikal has informed that it enclosed the transcript of the earnings call held on November 9, 2022.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.